Abstract:Objective To compare the abilities of Child-Turcotte-Pugh (CTP) score, Model for End-Stage Liver Disease (MELD), MELD combined with serum sodium concentration (MELD-Na), integrated MELD (iMELD), and MELD to SNa ratio (MESO) to predict short-term and medium-term death risks in patients with decompensated cirrhosis at months 3 and 12.Methods The records of 269 patients with decompensated cirrhosis in Department of Gastroenterology, West China Hospital, Sichuan University from January 1 to December 31, 2014 were retrospectively analyzed.The CTP, MELD, MELD-Na, iMELD, and MESO scores were evaluated for these patients within 48 hours after admission and these patients were followed up for at least 12 months.The predictive abilities of these five scoring systems were evaluated by the area under the receiver operating characteristic curve (AUC) at months 3 and 12.Comparison of continuous data was conducted using t test (for data with normal distribution and homogeneity of variance) or Mann-Whitney U test (for data with non-normal distribution), while comparison of categorical data was conducted usingχ2 test.Meanwhile, logistic regression analysis, Hosmer-Lemeshow goodness-of-fit test, and Kaplan-Meier survival analysis were performed.Results Twenty-five (9.29%) and thirty-eight (14.13%) of all patients died within 3 months and 12 months, respectively.There were significant differences between the patients who died and survived within 12 months in total bilirubin, creatinine, urea, albumin, white blood cell count, prothrombin time, international normalized ratio, serum sodium, the presence or absence of hepatic encephalopathy on admission, degree of ascites, the CTP, MELD, MELD-Na, iMELD, and MESO scores on admission, history of hepatic encephalopathy, and treatments for these factors after discharge (all P<0.05).The multivariate logistic regression analysis revealed that all five scores were independent prognostic factors for the patients (odds ratios: CTP=2.020, MELD=1.252, MELD-Na=1.088, iMELD=1.114, MESO=1.368;all P<0.01).At month 3, CTP score had the highest AUC (0.823), followed by MESO (0.796), MELD (0.789), MELD-Na (0.775), and iMELD (0.770) scores.At month 12, the AUC values for CTP, MELD, MELD-Na, iMELD, and MESO were 0.834, 0.798, 0777, 0.801, and 0.804, respectively.Therefore, CTP score was best in predicting the death risks within 3 and 12 months.The Kaplan-Meier curves showed that these five scoring methods clearly distinguished 12-month cumulative survival rates for these patients (all P<0.05).Conclusion CTP score, MELD score, and three MELD-related scores can reliably predict both short-term and medium-term death risks in patients with decompensated cirrhosis.Moreover, CTP score may have a better ability to predict death risks in patients with decompensated cirrhosis in China.

Comparison of Five Models for End-Stage Liver Disease in Predicting the Survival Rate of Patients with Advanced Hepatocellular Carcinoma.

Application of an end-stage liver disease model in prediction of prognosis in patients with liver cirrhosis

[Prognostic Value of the Model for End-Stage Liver Disease Combined with Serum Sodium Levels in Patients with Decompensated Cirrhosis].

An Evaluation of the Prognosis of Patients with Chronic Severe Hepatitis Using a Model for End-Stage Liver Disease

A Combination of Models for End-Stage Liver Disease and Cirrhosis-Related Complications to Predict the Prognosis of Liver Cirrhosis

A Modified Meld Model For Chinese Pre-Aclf And Aclf Patients And It Reveals Poor Prognosis In Pre-Aclf Patients

The Predicting Value of Model for End-Stage Liver Disease(meld) and MELD-Na for Shot-Term Prognosis of Patients with Decompensated Cirrhosis

Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients

Establishing a Metabolomic Model for the Prognosis of Hepatitis B Virus-Induced Acute-on-chronic Liver Failure Treated with Different Liver Support Systems

A Novel Integrated Model for End-Stage Liver Disease Model Predicts Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-chronic Liver Failure Patients.

The Model for End-stage Liver Disease 3.0 is Not Superior to the Model for End-stage Liver Disease-Na in Predicting Survival: A Retrospective Cohort Study.

Model for End-Stage Liver Disease-Sodium Predicts Prognosis in Patients with Chronic Severe Hepatitis B

Evidence-based Incorporation of Key Parameters into MELD Score for Acute-on-chronic Liver Failure

Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis.

Prognostic Assessment of Five Scoring Systems for Survival Rate of Advanced Hepatocellular Carcinoma

Comparison of the abilities of five scoring systems to predict short-term and medium-term death risks in patients with decompensated cirrhosis

Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model

Assessment of Prognosis and Curative Effect in Patients with Chronic Severe Hepatitis Using the Model for End-Stage Liver Disease Scores.

A Comparison of Child-Turcotte-Pugh Classification with Four Models of End-Stage Liver Disease-Based Prognostic System for Spontaneous Bacterial Peritionitis in Cirrhosis

Comparison of a New Prognostic System and Five Current Staging Systems in Predicting the Survival Rate of Patients with Advanced Hepatocellular Carcinoma.